CClinicalTrials.gg
TerminatedNCT03706430Updated Jun 18, 2026Results posted

Validation of RPVi as a Parameter to Predict Fluid Responsiveness

An interventional study of Pulse CO-Oximeter sensor in Surgery and Anesthesia, sponsored by Masimo Corporation. Terminated at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-18.

Sponsored by Masimo Corporation · Interventional and Other

Why this study was terminated
Sponsor requested
Study type
Interventional
Enrollment
63
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

This is a prospective, nonrandomized, sequential data collection study to evaluate the ability of RPVi to predict fluid responsiveness in comparison with other dynamic parameters including stroke volume variation (SVV) and/or pulse pressure variation (PPV).

02

Conditions studied

  • Surgery
  • Anesthesia
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • 18 years of age or older at the time of consent
  • Scheduled for elective surgery requiring general anesthesia and mechanical ventilation
  • Arterial line and other standard of care line placement indicated as part of the scheduled surgical procedure

Exclusion criteria

Exclusion Criteria:

  • Patients diagnosed with or history of heart failure, angina, pulmonary heart disease, rheumatic heart disease, cardiomyopathy, congenital heart disease, or valvular heart disease.
  • Patients scheduled for or has had a liver transplant
  • Patients with surgeries at or around site of sensor placement or skin abnormalities affecting the sensor placement area such as psoriasis, eczema, angioma, scar tissue, burn, fungal infection, substantial skin breakdown, nail polish or acrylic nails that would prevent monitoring of pulse-oximeter physiological parameters during the study.
  • Patients with cardiac arrhythmias
  • Patients with intracardiac shunts
04

Study design

Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
63 participants (actual)

Study arms

  • Experimental
    Pulse Co-Oximeter sensor

    All subjects are enrolled into this arm and will receive an investigational pulse CO-Oximeter sensors.

    Device: Pulse CO-Oximeter sensor

Interventions

  • DevicePulse CO-Oximeter sensor

    Investigational Pulse CO-Oximeter sensor will measure hemoglobin (SpHb), Pulse Rate (PR), Perfusion Index (Pi), Methemoglobin (SpMet), Pleth Variability Index (PVi), RPVi, etc.

05

What researchers measure

Primary outcomes

  1. Comparison of RPVi to SVV and/or PPV

    To evaluate the ability of RPVi to predict fluid responsiveness in comparison with other dynamic parameters including Stroke Volume Variation (SVV) and/or Pulse Pressure Variation (PPV) using Bland Altman analysis.

    Time frame: approximately 2-6 hours during surgery

06

Results

Posted Jun 22, 2023

Participant flow

Participant flow — Overall Study
MilestonePulse Co-Oximeter Sensor
Started63
Completed48
Not completed15
Withdrew: No a-line placed5
Withdrew: Subject had gel nail polish1
Withdrew: Nail length causing difficulties with sensor1
Withdrew: Cancelled case6
Withdrew: Physician decision2

Outcome measures

PrimaryComparison of RPVi to SVV and/or PPV

To evaluate the ability of RPVi to predict fluid responsiveness in comparison with other dynamic parameters including Stroke Volume Variation (SVV) and/or Pulse Pressure Variation (PPV) using Bland Altman analysis.

Time frame:
approximately 2-6 hours during surgery

No measurements were reported for this outcome.

Adverse events

Collected over 2-6 hours during surgery. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Pulse Co-Oximeter Sensor0/48 (0%)0/48 (0%)0/48 (0%)

Baseline characteristics

Age, Customized
Age, Customized(Participants)Pulse Co-Oximeter Sensor
≤ 18 years0
Between 18 and 65 years23
≥ 65 years25
Sex: Female, Male
Sex: Female, Male(Participants)Pulse Co-Oximeter Sensor
Female15
Male33
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)Pulse Co-Oximeter Sensor
American Indian or Alaskan Native0
Asian4
Native Hawaiian or Other Pacific Islander0
Black or African American1
White38
Unknown or Not Reported5
07

Study locations

1 site
  • University of California, Los Angeles
    Los Angeles, California 90095, United States
08

References and documents

Study documents

  • Protocol and statistical analysis plan · Feb 24, 2022

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Registry details

Key details

Study ID
NCT03706430
Lead sponsor
Masimo Corporation
Responsible party
Sponsor
First posted
Oct 16, 2018
Start date
Sep 24, 2018
Primary completion
Oct 20, 2021
Completion
Oct 20, 2021
Results posted
Jun 22, 2023
Last update
Jun 18, 2026

Oversight

View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion